Publication details

Molecularly driven therapy recommended by a molecular tumor board: Accessible option or privilege for a minority of patients? A single-center experience from the Czech Republic

Authors

EID Michal TUČEK Štěpán BEDNAŘÍKOVÁ Markéta BRANČÍKOVÁ Dagmar SLABÝ Ondřej

Year of publication 2023
Type Conference abstract
Citation

You are running an old browser version. We recommend updating your browser to its latest version.

More info